Overexpression of Fut 2, 4, and 8, and nuclear localization of Fut 4 in ovarian cancer cell lines induced by ascitic fluids from epithelial ovarian cancer patients.
Nayely Paulina Alvear-HernandezVerónica Ivonne Hernández-RamírezJulio César Villegas-PinedaJuan Carlos Osorio-TrujilloJosé Jesús Guzmán-MendozaDolores Gallardo-RincónAlfredo Toledo-LeyvaPatricia Talamás-RohanaPublished in: Cell biology international (2024)
Fucosyltransferases (Fut) regulate the fucosylation process associated with tumorogenesis in different cancer types. Ascitic fluid (AF) from patients diagnosed with advanced stage of epithelial ovarian cancer (EOC) is considered as a dynamic tumor microenvironment associated with poor prognosis. Previous studies from our laboratory showed increased fucosylation in SKOV-3 and OVCAR-3, cancer-derived cell lines, when these cells were incubated with AFs derived from patients diagnosed with EOC. In the present work we studied three fucosyltransferases (Fut 2, Fut 4, and Fut 8) in SKOV-3, OVCAR-3 and CAOV-3 cell lines in combination with five different AFs from patients diagnosed with this disease, confirming that all tested AFs increased fucosylation. Then, we demonstrate that mRNAs of these three enzymes were overexpressed in the three cell lines under treatment with AFs. SKOV-3 showed the higher overexpression of Fut 2, Fut 4, and Fut 8 in comparison with the control condition. We further confirmed, in the SKOV-3 cell line, by endpoint PCR, WB, and confocal microscopy, that the three enzymes were overexpressed, being Fut 4 the most overexpressed enzyme compared to Fut 2 and Fut 8. These enzymes were concentrated in vesicular structures with a homogeneous distribution pattern throughout the cytoplasm. Moreover, we found that among the three enzymes, only Fut 4 was located inside the nuclei. The nuclear location of Fut 4 was confirmed for the three cell lines. These results allow to propose Fut 2, Fut 4, and Fut 8 as potential targets for EOC treatment or as diagnostic tools for this disease.
Keyphrases
- poor prognosis
- end stage renal disease
- ejection fraction
- newly diagnosed
- cell proliferation
- prognostic factors
- squamous cell carcinoma
- long non coding rna
- patient reported outcomes
- papillary thyroid
- atrial fibrillation
- mass spectrometry
- young adults
- oxidative stress
- climate change
- risk assessment
- patient reported
- lymph node metastasis
- smoking cessation
- clinical evaluation
- genome wide analysis